Kommisjonens gjennomføringsforordning (EU) 2024/2781 av 31. oktober 2024 om endring av gjennomføringsforordning (EU) nr. 540/2011 med hensyn til forlengelse av godkjenningsperioden for de aktive stoffene 8-hydroxyquinoline, aminopyralid, azoxystrobin, Candida oleophila strain O, chlorantraniliprole, fluroxypyr, imazalil, kresoxim-metyl, metobromuron, oxyfluorfen, Paecilomyces fumosoroseus strain Fe 9901, tefluthrin og terbuthylazine
Plantevernmidler: forlenget godkjenning av visse aktive stoffer
Commission Implementing Regulation (EU) 2024/2781 of 31 October 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 8-hydroxyquinoline, aminopyralid, azoxystrobin, Candida oleophila strain O, chlorantraniliprole, fluroxypyr, imazalil, kresoxim-methyl, metobromuron, oxyfluorfen, Paecilomyces fumosoroseus strain FE 9901, tefluthrin and terbuthylazine
Kommisjonsforordning publisert i EU-tidende 4.11.2024
Tidligere
- Utkast til kommisjonsforordning godkjent av komite (representanter for medlemslandene) og publisert i EUs komitologiregister 14.10.2024
Nærmere omtale
BAKGRUNN (fra kommisjonsforordningen)
(1) Commission Implementing Regulation (EU) No 993/2011 approved the active substance 8-hydroxyquinoline until 31 December 2021. Commission Implementing Regulation (EU) No 891/2014 approved the active substance aminopyralid until 31 December 2024. Commission Implementing Regulation (EU) No 703/2011 approved the active substance azoxystrobin until 31 December 2021. Commission Implementing Regulation (EU) No 373/2013 approved the active substance Candida oleophila strain O until 30 September 2023. Commission Implementing Regulation (EU) No 1199/2013 approved the active substance chlorantraniliprole until 30 April 2024. Commission Implementing Regulation (EU) No 736/2011 approved the active substance fluroxypyr until 31 December 2021. Commission Implementing Regulation (EU) No 705/2011 approved the active substance imazalil until 31 December 2021. Commission Implementing Regulation (EU) No 810/2011 approved the active substance kresoxim-methyl until 31 December 2021. Commission Implementing Regulation (EU) No 890/2014 approved the active substance metobromuron until 31 December 2024. Commission Implementing Regulation (EU) No 798/2011 approved the active substance oxyfluorfen until 31 December 2021. Commission Implementing Regulation (EU) No 378/2013 approved the active substance Paecilomyces fumosoroseus strain FE 9901 until 30 September 2023. Commission Implementing Regulation (EU) No 800/2011 approved the active substance tefluthrin until 31 December 2021 and Commission Implementing Regulation (EU) No 820/2011 approved the active substance terbuthylazine until 31 December 2021.
(2) The respective approvals of the active substances 8-hydroxyquinoline, aminopyralid, azoxystrobin, Candida oleophila strain O, chlorantraniliprole, fluroxypyr, imazalil, kresoxim-methyl, metobromuron, oxyfluorfen, Paecilomyces fumosoroseus strain Fe 9901, tefluthrin and terbuthylazine are included in Part B of the Annex to Commission Implementing Regulation (EU) No 540/2011.
(3) Commission Implementing Regulation (EU) 2023/2592 extended the approval period of the active substance 8-hydroxyquinoline until 31 December 2024. (4) Commission Implementing Regulation (EU) 2019/291 extended the respective approval periods of the active substances azoxystrobin, fluroxypyr, imazalil, kresoxim-methyl, oxyfluorfen, tefluthrin and terbuthylazine until 31 December 2024.
(5) Commission Implementing Regulation (EU) 2020/200718 extended the respective approval periods of the active substances Candida oleophila strain O, chlorantraniliprole and Paecilomyces fumosoroseus strain Fe 9901 until 31 December 2024.